quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:16:05·79d
INSIDERFiling
Applied Therapeutics Inc. logo

Chief Commercial Officer Hooks Corwin Dale was granted 312,500 shares and returned 862,500 shares to the company, closing all direct ownership in the company (SEC Form 4)

APLT· Applied Therapeutics Inc.
Health Care
Original source

Companies

  • APLT
    Applied Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Dec 12UpdateRobert W. Baird-
  • Dec 3UpdateLeerink Partners$1.00
  • Dec 23UpdateWilliam Blair-
  • Dec 2UpdateUBS$2.00
  • Nov 29UpdateRBC Capital Mkts$4.00
  • Jul 31UpdateWilliam Blair-

Related

  • SEC69d
    SEC Form 15-12G filed by Applied Therapeutics Inc.
  • SEC74d
    SEC Form EFFECT filed by Applied Therapeutics Inc.
  • SEC74d
    SEC Form EFFECT filed by Applied Therapeutics Inc.
  • INSIDER78d
    Director Kanter Stacy J. returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Officer Chinoporos Constantine was granted 437,500 shares and returned 1,000,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Director Skyler Jay S returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Chief Financial Officer Funtleyder Leslie D. was granted 1,187,500 shares and returned 2,375,000 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER79d
    Chief Medical Officer Bailey Evan Prescott returned 1,235,915 shares to the company and was granted 437,500 shares, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022